Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Neuvonen

Showing results (141-150 of 334) with videos related to

Pageof 34
Sort By:
European Journal of Clinical Pharmacology|September 1, 1979
Pharmacokinetics of metformin after intravenous and oral administration to manP J Pentikäinen, P J Neuvonen, A Penttilä
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1987
Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseasesE Tiula, L G Tallgren, P J Neuvonen
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1987
Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseasesE Tiula, E J Haapanen, P J Neuvonen
British Journal of Clinical Pharmacology|May 13, 1998
Concentrations and effects of buspirone are considerably reduced by rifampicinT S Lamberg, K T Kivistö, P J Neuvonen
International Journal of Clinical Pharmacology and Biopharmacy|December 1, 1976
Effect of long-term alcohol consumption on the half-life of tetracycline and doxycycline in manP J Neuvonen, O Penttilä, M Roos, et al.
Pharmacology & Toxicology|April 8, 1999
Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaineM H Isohanni, P J Neuvonen, K T Olkkola
Pharmacology & Toxicology|May 5, 1999
Lack of effect of terfenadine on the pharmacokinetics of the CYP3A4 substrate buspironeT S Lamberg, K T Kivistö, P J Neuvonen
International Journal of Clinical Pharmacology and Biopharmacy|February 1, 1977
Factors affecting the bioavailability of phenytoinP J Neuvonen, P J Pentikäinen, S M Elfving
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1995
Azithromycin does not increase plasma concentrations of oral midazolamJ T Backman, K T Olkkola, P J Neuvonen
Clinical Pharmacology and Therapeutics|April 1, 1997
Itraconazole greatly increases plasma concentrations and effects of felodipineK M Jalava, K T Olkkola, P J Neuvonen
Pageof 34

Showing results (141-150 of 334) with videos related to

Sort By:
Pageof 34
European Journal of Clinical Pharmacology|September 1, 1979
Pharmacokinetics of metformin after intravenous and oral administration to manP J Pentikäinen, P J Neuvonen, A Penttilä
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1987
Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseasesE Tiula, L G Tallgren, P J Neuvonen
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1987
Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseasesE Tiula, E J Haapanen, P J Neuvonen
British Journal of Clinical Pharmacology|May 13, 1998
Concentrations and effects of buspirone are considerably reduced by rifampicinT S Lamberg, K T Kivistö, P J Neuvonen
International Journal of Clinical Pharmacology and Biopharmacy|December 1, 1976
Effect of long-term alcohol consumption on the half-life of tetracycline and doxycycline in manP J Neuvonen, O Penttilä, M Roos, et al.
Pharmacology & Toxicology|April 8, 1999
Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaineM H Isohanni, P J Neuvonen, K T Olkkola
Pharmacology & Toxicology|May 5, 1999
Lack of effect of terfenadine on the pharmacokinetics of the CYP3A4 substrate buspironeT S Lamberg, K T Kivistö, P J Neuvonen
International Journal of Clinical Pharmacology and Biopharmacy|February 1, 1977
Factors affecting the bioavailability of phenytoinP J Neuvonen, P J Pentikäinen, S M Elfving
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1995
Azithromycin does not increase plasma concentrations of oral midazolamJ T Backman, K T Olkkola, P J Neuvonen
Clinical Pharmacology and Therapeutics|April 1, 1997
Itraconazole greatly increases plasma concentrations and effects of felodipineK M Jalava, K T Olkkola, P J Neuvonen
Pageof 34